Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Clinical Laboratory Services Market, By Test Type
7.1. Clinical Laboratory Services Market, By Test Type, 2021-2028
7.1.1. Clinical Chemistry
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Human & Tumor Genetics
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Medical Microbiology & Cytology
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Other Esoteric Tests
7.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Clinical Laboratory Services Market, By Service Provider
8.1. Clinical Laboratory Services Market, By Service Provider, 2021-2028
8.1.1. Hospital-based Laboratories
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Stand-alone Laboratories
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Clinics-based Laboratories
8.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Clinical Laboratory Services Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.1.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.1.3.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.1.4.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.2.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.2.3.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.2.4.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.2.5.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.2.6.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.3.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.3.3.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.3.4.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.3.5.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.3.6.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.4.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.4.3.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.4.4.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.4.5.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.4.6.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.5.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.5.3.2. Market Revenue and Forecast, By Service Provider (2016-2028)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Test Type (2016-2028)
9.5.4.2. Market Revenue and Forecast, By Service Provider (2016-2028)
Chapter 10. Company Profiles
10.1. Holdings (LabCorp)
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Siemens AG
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Abbott Laboratories
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Quest Diagnostics
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Sonic Healthcare
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. OPKO Health, Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Neogenomics Laboratories, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Charles River Laboratories
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. ARUP Laboratories
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms